SQY Therapeutics, a biotechnology company based in Saint-Quentin-en-Yvelines, France, designs and produces antisense oligonucleotides of the tricyclo-DNA class. Objective: to implement R&D programs for genetic diseases, in particular neuromuscular diseases such as Duchenne Muscular Dystrophy.

SQY Therapeutics

Pascal FERRE

This department is responsible for conducting and overseeing clinical studies to evaluate the safety and efficacy of new treatments.

Clinical Research

This department focuses on the research and development of oligonucleotides and related chemical processes.

Oligonucleotide Chemistry

This department manages compliance with laws and regulations governing the organization.

SQY Therapeutics

Org chart

Teams

Clinical Research

Oligonucleotide Chemistry

Regulatory Affairs

Offices

SQY Therapeutics

Org chart

Teams

Clinical Research

Oligonucleotide Chemistry

Regulatory Affairs

Offices

Related companies